Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 9/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 9/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 9/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 8/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 8/20 | 1.00 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349663 | 1.00 | CHRM5 (1.00) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| Hydrochloric Acid SCHEMBL953398 | 0.98 | CHRM5 (0.96) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL7015792 | 0.94 | CHRM5 (0.89) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL9786179 | 0.76 | CHRM5 (0.61) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL3010648 | 0.76 | CHRM5 (0.61) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL7011586 | 0.75 | CHRM5 (0.60) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL16335774 | 0.74 | CHRM5 (0.59) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL7018605 | 0.73 | CHRM5 (0.56) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL22890955 | 0.73 | CHRM5 (0.57) | CHRM5CHRM3CHRM2CHRM1CHRM4 | |
| SCHEMBL18966709 | 0.73 | CHRM5 (0.57) | CHRM5CHRM3CHRM2CHRM1CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165510-B1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | HOFFMANN LA ROCHE (CH) | 2005-09-28 | — | — | EP | disclosed |
| EP-1165510-A1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-01-02 | — | — | EP | disclosed |
| US-6284785-B1 | HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS | HOFFMANN- LA ROCHE INC. | 2001-09-04 | — | — | US | disclosed |
| WO-2000058285-A1 | 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-10-05 | — | — | WO | disclosed |
| EP-0971929-A1 | 2,3-DIHYDROFURO 3,2-$i(b)]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY | SANOFI-SYNTHELABO (FR) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042713-A1 | 2,3-DIHYDROFURO[3,2-b]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY | SANOFI-SYNTHELABO (FR) | 1998-10-01 | — | — | WO | disclosed |